Interactive Features

________ yields tolerability for the prevention of acute graft-versus-host disease by inhibiting the migration of both naive and activated lymphocytes into gut-associated lymphoid tissues and the…
True or False: Due to increased toxicity and infection rates in older patients, dose intensification of induction treatment often is no justifiable option. Consequently, new treatment options are…
True or False: Ixazomib, an oral proteasome inhibitor, is ideal for multiple myeloma treatment due to a history of low rates of polyneuropathy and patient tolerability.
True or False: The addition of azacitidine to eprenetapopt led to significantly low rates of response and remission in a study of patients with TP53-mutant MDS and oligoblastic AML.
Is there a significant link between serum ferritin level and fibrosis in older patients with MF?
Prior to experts utilizing tyrosine kinase inhibitors as treatment for chronic myeloid leukemia, a stem cell transplant was required.
Which of the following combination treatment options has yielded the best outcomes in patients with stage IV GIST?
Stay in the know.
OncNet Newsletter